ClinicalTrials.gg
RecruitingNCT07277205Updated Oct 9, 2026

Comparison of Vestibular and Dual-Task Rehabilitation in Parkinson's Disease

An interventional study of Vestibular Rehabilitation and Cognitive-Motor Dual Task Activities in Parkinson Disease, sponsored by Marmara University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Marmara University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Updated Oct 9, 2026Now RecruitingFirst site in Turkey (Türkiye)+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 172 studies in Parkinson Disease with a site in Turkey — 50 open to participants now, 56 under way, none of them phase 3. Parkinson Disease · Turkey.

Planned enrollment
24th of 99
45 · median 32
Started
2026
with 28 others
No phase
92 of 172
26 open now
Primary completion
2027-06
later than 52 of 55 live
Registered
129th of 172
by date

Among the 172 studies in Parkinson Disease with a site in Turkey, this one is the 24th largest by planned enrollment of the 99 interventional ones that give a count, is one of 29 that started in 2026, is one of 92 with no phase, reaches primary completion later than 52 of the 55 other live ones, and was the 129th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

50 of the 172 studies in Parkinson Disease with a site in Turkey are open now. Recruiting first, the newest first:

44 more — sign in →

All 50 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 40 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 172 studies in Parkinson Disease with a site in Turkey, or all of them as a file.
02

Study summary

Parkinson's disease (PD) is a long-term condition that affects movement, balance, and thinking abilities. It can cause tremor, stiffness, slow movements, and difficulty maintaining balance. In addition to these physical problems, many people with PD also experience difficulties with memory, attention, and other cognitive functions. The balance system in the inner ear (vestibular system) helps maintain posture and orientation, but this system may not work properly in people with PD.

This study aims to compare two different types of exercise programs to improve movement, balance, and cognitive abilities in individuals with PD. One program focuses on exercises that stimulate the balance system (vestibular rehabilitation), while the other combines thinking and movement activities at the same time (dual-task training).

Thirty-six people with PD will take part in the study. Participants will be randomly assigned to one of three groups: vestibular exercise group, dual-task exercise group, or control group. Exercises will be done under the supervision of a physiotherapist twice a week for eight weeks. Each session will last about 40 minutes and include activities that are safe, structured, and personalized.

Before and after the 8-week program, participants will complete simple tests that measure their memory, attention, walking ability, balance, and daily activity level. The results will show whether these exercise approaches can help improve both body and brain functions.

The findings of this study are expected to help physiotherapists design more effective and personalized rehabilitation programs for people with Parkinson's disease, leading to better balance, safer movement, and improved quality of life.

Read the detailed description

Parkinson's disease (PD) is a chronic, progressive neurodegenerative disorder characterized by motor symptoms such as tremor, rigidity, bradykinesia, and postural instability, as well as non-motor symptoms including cognitive impairment and depression. Postural control depends on the integration of visual, somatosensory, and vestibular inputs, and this multisensory integration is often impaired in PD. Vestibular dysfunction can manifest as dizziness, imbalance, and spatial disorientation, leading to functional limitations, an increased risk of falls, and reduced independence. Moreover, the vestibular system is anatomically and functionally connected to brain regions involved in cognition, such as the hippocampus and frontal cortex. Therefore, targeting vestibular function in rehabilitation may improve not only balance but also cognitive performance.

Previous research has demonstrated that vestibular rehabilitation can improve balance, gait, and postural stability in individuals with PD. However, its potential effects on cognitive functions have been largely neglected. In parallel, dual-task training-based on the simultaneous performance of motor and cognitive tasks-has emerged as an evidence-based approach to improve both motor and cognitive outcomes. Studies have shown that dual-task exercise can enhance gait speed, step length, balance, attention, and executive function in PD. Nevertheless, no studies have directly compared the effects of vestibular rehabilitation and dual-task exercise training on cognitive and motor functions in this population.

The present study is designed to fill this gap by comparing these two rehabilitation approaches. A total of 36 participants diagnosed with PD will be recruited and randomly assigned into three groups: (1) vestibular rehabilitation, (2) cognitive-motor dual-task training, and (3) control. Each intervention will be administered twice weekly for eight weeks, with each session lasting approximately 40 minutes under the supervision of a physiotherapist. The vestibular rehabilitation program will include static and dynamic balance training, gaze stabilization, adaptation, habituation, and substitution exercises. The dual-task training program will integrate functional balance exercises with concurrent cognitive challenges (e.g., counting backward, naming tasks, or alternating verbal tasks). The control group will maintain their usual level of physical activity.

Assessments will be conducted before and after the 8-week intervention. Cognitive functions will be evaluated using the Digit Span Test, Word Fluency Test, and Clock Drawing Test. Motor functions will be assessed with the Mini-BESTest, Four Square Step Test, and Dynamic Gait Index, along with postural stability analysis using KFORCE Plates. Activity and participation will be evaluated using the Parkinson's Activity Scale and the Parkinson's Disease Questionnaire (PDQ-39).

Data will be analyzed using SPSS 21.0. Depending on normality assumptions, repeated-measures ANOVA or non-parametric alternatives will be used to assess within- and between-group differences. Statistical significance will be set at p \< 0.05.

This study is expected to provide new insights into the clinical impact of vestibular and dual-task rehabilitation on cognitive and motor outcomes in PD. The results may contribute to developing individualized, evidence-based physiotherapy protocols that integrate balance and cognitive training, ultimately improving functional independence and quality of life among individuals with Parkinson's disease.

03

Conditions studied

  • Parkinson Disease

Browse trials for

04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals aged between 40 and 75 years
  • Diagnosed with idiopathic Parkinson's disease (IPD)
  • Stable medication regimen within the past one month
  • Hoehn and Yahr stage I-III
  • A score of at least 22 on the (MoCA)
  • Participants evaluated during the "on" phase of their medication cycle
  • No hearing and/or visual impairments

Exclusion criteria

Exclusion Criteria:

  • Presence of any neurological, cardiovascular, or orthopedic disorder that may interfere with walking
  • Diagnosis of any other neurological disease (e.g., dementia, cerebrovascular disease)
  • Patients with deep brain stimulation (DBS) implants
  • Presence of vascular pathologies in the lower extremities
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    Vestibular Rehabilitation Group

    Other: Vestibular Rehabilitation

  • Experimental
    Cognitive-Motor Dual Task Activities Group

    Other: Cognitive-Motor Dual Task Activities

  • No intervention
    Control Group

Interventions

  • OtherVestibular Rehabilitation

    Vestibular exercises will consist of static and dynamic balance exercises, VOR and eye movement training, central balance strategies and static-dynamic balance, adaptation, substitution, habituation exercises in terms of adapting to the balance system.

  • OtherCognitive-Motor Dual Task Activities

    In the Cognitive-Motor Dual Task Activities Group, patients will be given additional cognitive tasks (e.g. counting months, subtracting 5 from 100, etc.) in line with the physiotherapist's commands simultaneously with balance and functional activities (such as stepping forwards-sideways-backwards, sitting-standing).

06

What researchers measure

Primary outcomes

  1. Mini-BESTest Total Score

    Dynamic balance will be assessed using the Mini-BESTest, consisting of 14 items scored from 0-2. The total score (0-28) will be used as the primary outcome, with higher scores indicating better balance and postural control. Unit of Measure: Points (0-28)

    Time frame: Baseline and Week 8

  2. Semantic Verbal Fluency Test (Semantic Fluency, 60 seconds)

    Participants will name as many semantic-category words as possible within 60 seconds. The outcome will be the total number of correct words produced. Unit of Measure: Number of words

    Time frame: Baseline and Week 8

Secondary outcomes

  1. Digit Span Test (Forward and Backward)

    Attention and working memory will be evaluated using the Digit Span Test. Numbers are read at one-per-second pace, and participants repeat increasingly longer sequences forward and backward. Outcome: maximum correctly recalled span for each condition. Unit of Measure: Digit span (number of digits)

    Time frame: Baseline and Week 8

  2. Clock Drawing Test (Manos & Wu Scoring Method)

    Visuospatial and executive functions will be assessed by drawing "10 past 11" on a pre-segmented circle. Correct placement of 8 numbers and 2 clock hands are scored. Total score ranges from 0 to 10. Unit of Measure: Points (0-10)

    Time frame: Baseline and Week 8

  3. Four Square Step Test (FSST)

    Participants step clockwise and counterclockwise through four squares following a fixed sequence. Time to complete the sequence is recorded. The best of two trials will be used. Unit of Measure: Seconds

    Time frame: Baseline and Week 8

  4. Dynamic Gait Index (DGI) Total Score

    Dynamic balance during gait will be assessed using the Dynamic Gait Index. Eight items are scored from 0-3, with a maximum score of 24. Higher scores indicate better performance. Unit of Measure: Points (0-24)

    Time frame: Baseline and Week 8

  5. Postural Stability (KFORCE Plates - Center of Pressure Metrics)

    Static and dynamic balance parameters (e.g., center-of-pressure displacement, sway, weight distribution) will be recorded using KFORCE force plates. Objective biomechanical data will be extracted from standardized stance and movement conditions. Unit of Measure: Center of pressure metrics (mm or mm/s)

    Time frame: Baseline and Week 8

  6. Parkinson Activity Scale (PAS) Total Score

    Functional mobility and activity performance will be assessed using the Parkinson Activity Scale. Scores range from 0 to 4 for each item, with higher scores indicating better functional ability. Unit of Measure: Points

    Time frame: Baseline and Week 8

  7. Parkinson's Disease Quality of Life Questionnaire (PDQ-39) Total Score

    Quality of life will be measured with the PDQ-39, a 39-item questionnaire evaluating mobility, daily activities, emotional well-being, cognition, communication, and social functioning. Scores range 0-100, with higher scores indicating poorer quality of life. Unit of Measure: Total score (0-100)

    Time frame: Baseline and Week 8

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Jun 2027, 15 months after the start.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 15 months is below that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

Start moved once since we started tracking on Sep 25, 2026: Jan 2026 → Mar 2026, on Oct 9, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2025
First posted
Dec 11, 2025
StartActual
Mar 3, 2026was Jan 2026
Primary completionEst.
Jun 2027
CompletionEst.
Aug 2027
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 9, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Marmara University · Istanbul, Turkey (Türkiye)
Oct 9, 2026
Start date
Jan 2026→Mar 3, 2026 (actual)
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Marmara University · Istanbul, Turkey (Türkiye)
    Start date Jan 2026→Mar 3, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07277205
Lead sponsor
Marmara University
Responsible party
Ezgi Eryıldız (Research assistant, Marmara University) — Principal investigator
First posted
Dec 11, 2025
Start date
Mar 3, 2026
Primary completion
Jun 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Oct 9, 2026

Study contacts

Ezgi Eryıldız, PhD (c)
Contact
fzt.ezgigul@gmail.com
+905071180878

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion